NCT02302326View on ClinicalTrials.gov

Involvement of Reticulum Endoplasmic Stress in the Physiopathology of Polycystic Ovary Syndrome

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

Metformin

Dose: metformin (1700 mg / day) for 12 weeks

DIETARY_SUPPLEMENT

Myo-inositol + folic acid

Dose: Ovusitol® (4 g myo-inositol plus 400 micrograms of folic acid/day) for 12 weeks

Trial Locations (1)

46017

Antonio Hernández, Valencia

All Listed Sponsors
lead

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

OTHER

NCT02302326 - Involvement of Reticulum Endoplasmic Stress in the Physiopathology of Polycystic Ovary Syndrome | Biotech Hunter | Biotech Hunter